Related Experiment Video
Updated: Aug 8, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
Emerging role of antibiotics in atherosclerosis
1Coronary Care Unit, Fundación Favaloro, Argentina. gurfi001@ffinme.edu.ar
Abstract:
It has been shown that plaque composition changes significantly in the setting of acute events, macrophages and T cells being the predominant pattern at the immediate site of fissure or erosion. There appears to be a relation between physical blood stream factors, plaque morphology, and the distribution of inflammatory cells. Furthermore, there is cumulative evidence for the presence of intracellular pathogens in the arterial wall, namely Chlamydia pneumoniae and cytomegalovirus, which affect endothelial cells, monocytes, and macrophages. The ROXIS trial has shown some encouraging evidences for the potential role of intracellular pathogens in acute coronary syndromes. The ongoing WIZARD trial evaluates in a large population whether the addition of an antibiotic provides better outcome for coronary patients.
Insights
Inflammation and pathogens like Chlamydia pneumoniae may drive acute coronary syndromes. The WIZARD trial investigates if antibiotics improve outcomes for coronary heart disease patients.
Area of Science:
- Cardiovascular Medicine
- Infectious Disease Immunology
Background:
- Plaque composition shifts during acute cardiovascular events, with macrophages and T cells dominating.
- Blood flow dynamics, plaque structure, and inflammatory cell distribution are interconnected.
- Intracellular pathogens, including Chlamydia pneumoniae and cytomegalovirus, are implicated in arterial wall inflammation.
Purpose of the Study:
- To explore the role of intracellular pathogens in acute coronary syndromes.
- To evaluate the efficacy of antibiotic treatment in coronary heart disease patients.
Main Methods:
- Analysis of plaque composition in acute cardiovascular events.
- Review of evidence for intracellular pathogens in atherosclerosis.
- Evaluation of clinical trial data (ROXIS and WIZARD trials).
Main Results:
- Macrophages and T cells are key inflammatory cells at sites of plaque rupture.
- Evidence suggests intracellular pathogens affect vascular cells and macrophages.
- The ROXIS trial indicated a potential role for pathogens in acute coronary syndromes.
Conclusions:
- Intracellular pathogens may contribute to acute coronary syndromes.
- The WIZARD trial is assessing the benefit of antibiotics for improved outcomes in coronary patients.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
11:59Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
Published on: May 15, 2019
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Microbiota Modulation by Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance